These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25522033)

  • 1. Sample size and robust marginal methods for cluster-randomized trials with censored event times.
    Zhong Y; Cook RJ
    Stat Med; 2015 Mar; 34(6):901-23. PubMed ID: 25522033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
    Kombrink K; Munk A; Friede T
    Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantile regression models with multivariate failure time data.
    Yin G; Cai J
    Biometrics; 2005 Mar; 61(1):151-61. PubMed ID: 15737088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiparametric inference for surrogate endpoints with bivariate censored data.
    Ghosh D
    Biometrics; 2008 Mar; 64(1):149-56. PubMed ID: 17651457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials.
    Scott JM; deCamp A; Juraska M; Fay MP; Gilbert PB
    Stat Methods Med Res; 2017 Apr; 26(2):583-597. PubMed ID: 25267551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and analysis of cluster randomized trials with time-to-event outcomes under the additive hazards mixed model.
    Blaha O; Esserman D; Li F
    Stat Med; 2022 Oct; 41(24):4860-4885. PubMed ID: 35908796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size adjustments for varying cluster sizes in cluster randomized trials with binary outcomes analyzed with second-order PQL mixed logistic regression.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2010 Jun; 29(14):1488-501. PubMed ID: 20101669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive design: estimation and inference with censored data in a semiparametric model.
    Shen Y; Cheng Y
    Biostatistics; 2007 Apr; 8(2):306-22. PubMed ID: 16787996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A parametric model for cluster correlated categorical data.
    Meester SG; MacKay J
    Biometrics; 1994 Dec; 50(4):954-63. PubMed ID: 7787008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficiency and sample size for cluster randomized trials with variable cluster sizes.
    You Z; Williams OD; Aban I; Kabagambe EK; Tiwari HK; Cutter G
    Clin Trials; 2011 Feb; 8(1):27-36. PubMed ID: 21163852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
    Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
    Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving small-sample inference in group randomized trials with binary outcomes.
    Westgate PM; Braun TM
    Stat Med; 2011 Feb; 30(3):201-10. PubMed ID: 21213338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal analysis of correlated failure time data with informative cluster sizes.
    Cong XJ; Yin G; Shen Y
    Biometrics; 2007 Sep; 63(3):663-72. PubMed ID: 17825000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval-censored parametric regression survival models and the analysis of longitudinal trials.
    Mackenzie G; Peng D
    Stat Med; 2013 Jul; 32(16):2804-22. PubMed ID: 23297174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust tests for treatment effects based on censored recurrent event data observed over multiple periods.
    Cook RJ; Wei W; Yi GY
    Biometrics; 2005 Sep; 61(3):692-701. PubMed ID: 16135020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
    Boyd AP; Kittelson JM; Gillen DL
    Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculations for 3-level cluster randomized trials.
    Teerenstra S; Moerbeek M; van Achterberg T; Pelzer BJ; Borm GF
    Clin Trials; 2008; 5(5):486-95. PubMed ID: 18827041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracluster correlation adjustments to maintain power in cluster trials for binary outcomes.
    Chakraborty H; Moore J; Hartwell TD
    Contemp Clin Trials; 2009 Sep; 30(5):473-80. PubMed ID: 19386285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.